Nikkei Biotech featured our pipeline to capture the global market in the article “Clinical Development Pipeline of Drug Discovery Start-Ups 2024”

July 10, 2024
J-Pharma Co., Ltd.

PDF for Print

Nikkei Biotech featured our pipeline to capture the global market in the article “Clinical Development Pipeline of Drug Discovery Start-Ups 2024”.
~J-Pharma – LAT1 Inhibitor Enters Global Phase 3~

https://bio.nikkeibp.co.jp/atcl/report/16/082400016/070400350/

Inquiries:
J-Pharma Co., Ltd.
Administration Department
Public Relations
Tel: 045-506-1155
Fax: 045-506-1156
info@j-pharma.com